Lentinan In-Situ Coated Tungsten Oxide Nanorods As a Nanotherapeutic Agent for Low Power Density Photothermal Cancer Therapy.

Yilong Tian,Wenhui Yi,Lei Bai,Ping Zhang,Jinhai Si,Xun Hou,Yating Deng,Jin Hou
DOI: https://doi.org/10.1016/j.ijbiomac.2019.06.183
IF: 8.2
2019-01-01
International Journal of Biological Macromolecules
Abstract:Development of high photothermal performance and biocompatible nanotherapeutic agents is of great importance for photothermal cancer treatment. In this paper, we have developed lentinan decorated tungsten oxide nanorods (W18O49@LTN NRs) via a mild one-step solvothermal route. Owing to the numerous surface hydroxyl groups of polymer chains, the presence of lentinan layer in the surface of W18O49 NRs lead to good biocompatibility. The lentinan layer also affects the crystal structure of W18O49 and improves near-infrared absorption (similar to 1.7 x 10(9) M-1 cm(-1) at 980 nm), which is two orders of higher than previously reported PEGylated W18O49 nano wires. Even under near-infrared (NIR) laser irradiation at a very low power density of 0.4 W/cm(2), the temperature of W18O49@LTN NRs aqueous dispersion (125 mu g/mL) could increase by 15.1 degrees C. The photothermal conversion efficiency of W18O49@LTN NRs reaches 33.86%, which is higher than previously reported WO3-x hierarchical nanostructures (28.1%). Importantly, when cancer cells were treated with W18O49@LIN NRs (200 mu g/mL) and 980 nm laser (0.4 W/cm(2)), a significant photo-induced cell killing behavior was observed. This work demonstrates that W18O49@LTN NRs have the potential for precise cancer treatment. (C) 2019 Elsevier B.V. All rights reserved.
What problem does this paper attempt to address?